| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 875.162.620 $ | 99,51 | 13.725.913 | ||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 177.917.449 $ | 20,23 | 148.335 | |
| Novartis AG | Novartis AG | EC | 66987V109 | Long | Börsenkurs (Stufe 1) | 93.444.770 $ | 10,63 | 596.253 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 86.583.943 $ | 9,85 | 673.805 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 47.189.979 $ | 5,37 | 984.355 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 40.231.952 $ | 4,57 | 159.879 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 39.637.727 $ | 4,51 | 1.646.085 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 39.303.870 $ | 4,47 | 682.122 | |
| GSK PLC | GSK PLC | EC | 37733W204 | Long | Börsenkurs (Stufe 1) | 38.852.551 $ | 4,42 | 741.178 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 38.296.898 $ | 4,35 | 150.793 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 38.107.173 $ | 4,33 | 200.966 | |
| McKesson Corp | McKesson Corp | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 36.254.444 $ | 4,12 | 47.981 | |
| Sanofi SA | Sanofi SA | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 35.212.844 $ | 4,00 | 825.430 | |
| Cencora Inc | Cencora Inc | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 29.513.965 $ | 3,36 | 104.297 | |
| Haleon PLC | Haleon PLC | EC | 405552100 | Long | Börsenkurs (Stufe 1) | 27.181.565 $ | 3,09 | 2.913.351 | |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 26.892.961 $ | 3,06 | 793.771 | |
| Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd | EC | 874060205 | Long | Börsenkurs (Stufe 1) | 25.255.666 $ | 2,87 | 1.575.525 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 18.456.882 $ | 2,10 | 256.845 | |
| Viatris Inc | Viatris Inc | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 9.630.188 $ | 1,10 | 606.435 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 9.502.893 $ | 1,08 | 39.436 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 6.752.960 $ | 0,77 | 27.589 | |
| Corcept Therapeutics Inc | Corcept Therapeutics Inc | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 4.431.320 $ | 0,50 | 50.964 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 3.106.323 $ | 0,35 | 126.222 | |
| Organon & Co | Organon & Co | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 2.014.982 $ | 0,23 | 148.817 | |
| Bausch Health Cos Inc | Bausch Health Cos Inc | EC | 071734107 | Long | Börsenkurs (Stufe 1) | 860.862 $ | 0,10 | 174.617 | |
| Perrigo Co PLC | Perrigo Co PLC | EC | IE00BGH1M568 | Long | Börsenkurs (Stufe 1) | 528.456 $ | 0,06 | 50.862 | |
| Gesamt | 875.162.620 $ | 99,51 | 13.725.913 |